Martin John Richard 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Jun 24, 2022
Insider Transaction Report
Form 4
Martin John Richard
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-23+18,500→ 18,500 totalExercise: $13.98Exp: 2032-06-22→ Common Stock (18,500 underlying)
Footnotes (1)
- [F1]This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 23, 2023, subject to continued service through such date.